Cargando…
Protease XIV abolishes NHE inhibition by empagliflozin in cardiac cells
Background: SGLT2i directly inhibit the cardiac sodium-hydrogen exchanger-1 (NHE1) in isolated ventricular cardiomyocytes (CMs). However, other studies with SGLT2i have yielded conflicting results. This may be explained by methodological factors including cell isolation techniques, cell types and am...
Autores principales: | Chen, Sha, Schumacher, Cees A., Van Amersfoorth, Shirley C. M., Fiolet, Jan W. T., Baartscheer, Antonius, Veldkamp, Marieke W., Coronel, Ruben, Zuurbier, Coert J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10410854/ https://www.ncbi.nlm.nih.gov/pubmed/37565139 http://dx.doi.org/10.3389/fphys.2023.1179131 |
Ejemplares similares
-
Sodium-glucose co-transporter 2 inhibitor empagliflozin inhibits the cardiac Na(+)/H(+) exchanger 1: persistent inhibition under various experimental conditions
por: Zuurbier, Coert J, et al.
Publicado: (2021) -
Empagliflozin decreases myocardial cytoplasmic Na(+) through inhibition of the cardiac Na(+)/H(+) exchanger in rats and rabbits
por: Baartscheer, Antonius, et al.
Publicado: (2016) -
The Driving Force of the Na(+)/Ca(2+)-Exchanger during Metabolic Inhibition
por: Baartscheer, Antonius, et al.
Publicado: (2011) -
Direct Cardiac Actions of Sodium Glucose Cotransporter 2 Inhibitors Target Pathogenic Mechanisms Underlying Heart Failure in Diabetic Patients
por: Uthman, Laween, et al.
Publicado: (2018) -
Class effects of SGLT2 inhibitors in mouse cardiomyocytes and hearts: inhibition of Na(+)/H(+) exchanger, lowering of cytosolic Na(+) and vasodilation
por: Uthman, Laween, et al.
Publicado: (2017)